Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
295M
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
48.2M
-
Shares change
-
+3.24M
-
Total reported value, excl. options
-
$871M
-
Value change
-
+$75.3M
-
Put/Call ratio
-
0.09
-
Number of buys
-
88
-
Number of sells
-
-45
-
Price
-
$18.08
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q1 2014
165 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q1 2014.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.2M shares
of 295M outstanding shares and own 16.35% of the company stock.
Largest 10 shareholders include FMR LLC (6.12M shares), RA CAPITAL MANAGEMENT, LLC (5.22M shares), WASATCH ADVISORS INC (3.13M shares), ADAGE CAPITAL PARTNERS GP LLC (2.8M shares), BlackRock Fund Advisors (2.63M shares), JENNISON ASSOCIATES LLC (2.02M shares), VANGUARD GROUP INC (1.96M shares), State Street Corp (1.9M shares), BlackRock Institutional Trust Company, N.A. (1.81M shares), and FRONTIER CAPITAL MANAGEMENT CO LLC (1.32M shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.